We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
101
Qualcomm
QCOM
$176B
$4.67M 0.14%
27,325
+1,239
+5% +$212K
DHR icon
102
Danaher
DHR
$135B
$4.66M 0.14%
20,369
+968
+5% +$213K
CTAS icon
103
Cintas
CTAS
$82.4B
$4.64M 0.14%
24,690
+3,180
+15% +$599K
LOW icon
104
Lowe's Companies
LOW
$116B
$4.4M 0.13%
18,237
+1,871
+11% +$449K
ACN icon
105
Accenture
ACN
$89.9B
$4.39M 0.13%
16,370
-1,175
-7% -$299K
NEE icon
106
NextEra Energy
NEE
$187B
$4.33M 0.13%
53,970
+1,510
+3% +$125K
MFG icon
107
Mizuho Financial
MFG
$129B
$4.3M 0.13%
588,049
+156,042
+36% +$1.07M
T icon
108
AT&T
T
$165B
$4.26M 0.13%
171,352
-590
-0.3% -$14.9K
PFE icon
109
Pfizer
PFE
$140B
$4.24M 0.13%
170,213
-1,971
-1% -$49.7K
LIN icon
110
Linde
LIN
$237B
$4.23M 0.13%
9,913
-3,395
-26% -$1.45M
IWR icon
111
iShares Russell Mid-Cap ETF
IWR
$56.8B
$4.19M 0.13%
43,510
+3,034
+7% +$292K
PLD icon
112
Prologis
PLD
$138B
$4.17M 0.13%
32,630
+3,177
+11% +$396K
ADBE icon
113
Adobe
ADBE
$89.5B
$4.15M 0.13%
11,852
+4,515
+62% +$1.54M
AMP icon
114
Ameriprise Financial
AMP
$46.8B
$4.14M 0.13%
8,449
-403
-5% -$191K
SCHW
115
Charles Schwab
SCHW
$177B
$4.14M 0.13%
41,406
+145
+0.4% +$13.8K
BKNG icon
116
Booking.com
BKNG
$138B
$4.13M 0.12%
19,300
+1,000
+5% +$206K
GILD icon
117
Gilead Sciences
GILD
$161B
$4.13M 0.12%
33,652
+250
+0.7% +$30.4K
AGG icon
118
iShares Core US Aggregate Bond ETF
AGG
$138B
$4.06M 0.12%
40,641
+4,953
+14% +$497K
CRM icon
119
Salesforce
CRM
$134B
$4.05M 0.12%
15,305
-7,631
-33% -$1.9M
ACWX icon
120
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$4.03M 0.12%
60,051
BHP icon
121
BHP
BHP
$213B
$4M 0.12%
66,308
-842
-1% -$47.8K
UL icon
122
Unilever
UL
$131B
$3.99M 0.12%
60,933
+1,376
+2% +$92.5K
ETN icon
123
Eaton
ETN
$157B
$3.97M 0.12%
12,465
+75
+0.6% +$26.6K
BA icon
124
Boeing
BA
$165B
$3.91M 0.12%
18,009
+934
+5% +$192K
BCS icon
125
Barclays
BCS
$94.1B
$3.9M 0.12%
153,166
+815
+0.5% +$18.1K

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.